Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Whole-exome sequencing of lobular endocervical glandular hyperplasia.

Ida K, Miyamoto T, Takatsu A, Ando H, Asaka R, Takeuchi H, Ono M, Yamada S, Asaka S, Shiozawa T.

Oncol Lett. 2019 Sep;18(3):2592-2597. doi: 10.3892/ol.2019.10549. Epub 2019 Jun 28.

2.

Sawtooth fetal heart rate pattern associated with a favorable neurological outcome in an infant: a case report.

Ohira S, Yamanaka S, Asaka R, Ando H, Fuseya C, Kikuchi N, Miyamoto T, Kanai M, Shiozawa T.

J Med Case Rep. 2019 Jul 25;13(1):226. doi: 10.1186/s13256-019-2170-0.

3.

Trophoblast type-specific expression of senescence markers in the human placenta.

Higuchi S, Miyamoto T, Kobara H, Yamada S, Asaka R, Kikuchi N, Kashima H, Ohira S, Shiozawa T.

Placenta. 2019 Sep 15;85:56-62. doi: 10.1016/j.placenta.2019.06.377. Epub 2019 Jun 28.

PMID:
31327484
4.

Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer.

Udupa S, Nguyen S, Hoang G, Nguyen T, Quinones A, Pham K, Asaka R, Nguyen K, Zhang C, Elgogary A, Jung JG, Xu Q, Fu J, Thomas AG, Tsukamoto T, Hanes J, Slusher BS, Cooper AJL, Le A.

Proteomics. 2019 Jun 24:e1800451. doi: 10.1002/pmic.201800451. [Epub ahead of print]

PMID:
31231915
5.

Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer.

Nguyen T, Kirsch BJ, Asaka R, Nabi K, Quinones A, Tan J, Antonio MJ, Camelo F, Li T, Nguyen S, Hoang G, Nguyen K, Udupa S, Sazeides C, Shen YA, Elgogary A, Reyes J, Zhao L, Kleensang A, Chaichana KL, Hartung T, Betenbaugh MJ, Marie SK, Jung JG, Wang TL, Gabrielson E, Le A.

Cell Rep. 2019 Apr 9;27(2):491-501.e6. doi: 10.1016/j.celrep.2019.03.036.

6.

Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.

Yen TT, Miyamoto T, Asaka S, Chui MH, Wang Y, Lin SF, Stone RL, Fader AN, Asaka R, Kashima H, Shiozawa T, Wang TL, Shih IM, Tanner EJ 3rd.

Gynecol Oncol. 2018 Sep;150(3):426-431. doi: 10.1016/j.ygyno.2018.06.025. Epub 2018 Jul 4.

PMID:
30126589
7.

Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions.

Pisanic TR 2nd, Cope LM, Lin SF, Yen TT, Athamanolap P, Asaka R, Nakayama K, Fader AN, Wang TH, Shih IM, Wang TL.

Clin Cancer Res. 2018 Dec 15;24(24):6536-6547. doi: 10.1158/1078-0432.CCR-18-1199. Epub 2018 Aug 14.

PMID:
30108103
8.

Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response.

Sakamoto K, Katayama R, Asaka R, Sakata S, Baba S, Nakasone H, Koike S, Tsuyama N, Dobashi A, Sasaki M, Ichinohasama R, Takakuwa E, Yamazaki R, Takizawa J, Maeda T, Narita M, Izutsu K, Kanda Y, Ohshima K, Takeuchi K.

Leukemia. 2018 Dec;32(12):2590-2603. doi: 10.1038/s41375-018-0154-5. Epub 2018 May 23.

PMID:
29795241
9.

Mutation analysis by whole exome sequencing of endometrial hyperplasia and carcinoma in one patient: Abnormalities of polymerase epsilon and the phosphatidylinositol-3 kinase pathway.

Miyamoto T, Ando H, Asaka R, Yamada Y, Shiozawa T.

J Obstet Gynaecol Res. 2018 Jan;44(1):179-183. doi: 10.1111/jog.13459. Epub 2017 Oct 6.

PMID:
28984400
10.

Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.

Tsuyama N, Asaka R, Dobashi A, Baba S, Mishima Y, Ueda K, Oguchi M, Tsuji H, Hatake K, Takeuchi K.

Hematol Oncol. 2018 Feb;36(1):328-335. doi: 10.1002/hon.2459. Epub 2017 Jul 10.

PMID:
28695659
11.

SIRT1 Regulates the Chemoresistance and Invasiveness of Ovarian Carcinoma Cells.

Mvunta DH, Miyamoto T, Asaka R, Yamada Y, Ando H, Higuchi S, Ida K, Kashima H, Shiozawa T.

Transl Oncol. 2017 Aug;10(4):621-631. doi: 10.1016/j.tranon.2017.05.005. Epub 2017 Jun 28.

12.

Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.

Tsuyama N, Ennishi D, Yokoyama M, Baba S, Asaka R, Mishima Y, Terui Y, Hatake K, Takeuchi K.

Oncotarget. 2017 May 16;8(20):33487-33500. doi: 10.18632/oncotarget.16532.

13.

Prenatal sonographic diagnosis of fetal valproate syndrome: a case report.

Kikuchi N, Ohira S, Asaka R, Tanaka K, Takatsu A, Shiozawa T.

J Med Case Rep. 2016 Nov 3;10(1):312.

14.

Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells.

Miyamoto T, Kashima H, Yamada Y, Kobara H, Asaka R, Ando H, Higuchi S, Ida K, Mvunta DH, Shiozawa T.

PLoS One. 2016 May 11;11(5):e0155220. doi: 10.1371/journal.pone.0155220. eCollection 2016.

15.

Overexpression of SIRT1 is Associated With Poor Outcomes in Patients With Ovarian Carcinoma.

Mvunta DH, Miyamoto T, Asaka R, Yamada Y, Ando H, Higuchi S, Ida K, Kashima H, Shiozawa T.

Appl Immunohistochem Mol Morphol. 2017 Jul;25(6):415-421. doi: 10.1097/PAI.0000000000000316.

PMID:
26862948
16.

ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.

Sakamoto K, Nakasone H, Togashi Y, Sakata S, Tsuyama N, Baba S, Dobashi A, Asaka R, Tsai CC, Chuang SS, Izutsu K, Kanda Y, Takeuchi K.

Int J Hematol. 2016 Apr;103(4):399-408. doi: 10.1007/s12185-016-1934-1. Epub 2016 Jan 18. Review.

PMID:
26781614
17.

Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.

Dobashi A, Tsuyama N, Asaka R, Togashi Y, Ueda K, Sakata S, Baba S, Sakamoto K, Hatake K, Takeuchi K.

Genes Chromosomes Cancer. 2016 May;55(5):460-71. doi: 10.1002/gcc.22348. Epub 2016 Feb 10.

PMID:
26773734
18.

Lipocalin 2 attenuates iron-related oxidative stress and prolongs the survival of ovarian clear cell carcinoma cells by up-regulating the CD44 variant.

Yamada Y, Miyamoto T, Kashima H, Kobara H, Asaka R, Ando H, Higuchi S, Ida K, Shiozawa T.

Free Radic Res. 2016;50(4):414-25. doi: 10.3109/10715762.2015.1134795. Epub 2016 Feb 12.

PMID:
26729415
19.

Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target.

Asaka R, Miyamoto T, Yamada Y, Ando H, Mvunta DH, Kobara H, Shiozawa T.

Lab Invest. 2015 Dec;95(12):1363-73. doi: 10.1038/labinvest.2015.119. Epub 2015 Sep 14.

20.

Lipocalin2 enhances the matrix metalloproteinase-9 activity and invasion of extravillous trophoblasts under hypoxia.

Kobara H, Miyamoto T, Suzuki A, Asaka R, Yamada Y, Ishikawa K, Kikuchi N, Ohira S, Shiozawa T.

Placenta. 2013 Nov;34(11):1036-43. doi: 10.1016/j.placenta.2013.08.004. Epub 2013 Aug 20.

PMID:
23972287
21.

Immunohistochemical expression of core 2 β1,6-N-acetylglucosaminyl transferase 1 (C2GnT1) in endometrioid-type endometrial carcinoma: a novel potential prognostic factor.

Miyamoto T, Suzuki A, Asaka R, Ishikawa K, Yamada Y, Kobara H, Nakayama J, Shiozawa T.

Histopathology. 2013 Jun;62(7):986-93. doi: 10.1111/his.12107. Epub 2013 Apr 26.

PMID:
23617619
22.

A low-grade B-cell lymphoma with prolymphocytic/paraimmunoblastic proliferation and IRF4 rearrangement.

Takeuchi K, Sakata S, Asaka R, Tsuyama N, Dobashi A, Noguchi M.

Haematologica. 2013 Mar;98(3):e32-5. doi: 10.3324/haematol.2012.076851. Epub 2013 Jan 8. No abstract available.

23.

KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only.

Togashi Y, Soda M, Sakata S, Sugawara E, Hatano S, Asaka R, Nakajima T, Mano H, Takeuchi K.

PLoS One. 2012;7(2):e31323. doi: 10.1371/journal.pone.0031323. Epub 2012 Feb 8.

24.

RET, ROS1 and ALK fusions in lung cancer.

Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, Hatano S, Asaka R, Hamanaka W, Ninomiya H, Uehara H, Lim Choi Y, Satoh Y, Okumura S, Nakagawa K, Mano H, Ishikawa Y.

Nat Med. 2012 Feb 12;18(3):378-81. doi: 10.1038/nm.2658.

PMID:
22327623
25.

Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.

Sugawara E, Togashi Y, Kuroda N, Sakata S, Hatano S, Asaka R, Yuasa T, Yonese J, Kitagawa M, Mano H, Ishikawa Y, Takeuchi K.

Cancer. 2012 Sep 15;118(18):4427-36. doi: 10.1002/cncr.27391. Epub 2012 Jan 17.

26.

Immunohistochemical expression of keratan sulfate: a possible diagnostic marker for carcinomas of the female genital tract.

Miyamoto T, Ishii K, Asaka R, Suzuki A, Takatsu A, Kashima H, Shiozawa T.

J Clin Pathol. 2011 Dec;64(12):1058-63. doi: 10.1136/jclinpath-2011-200231. Epub 2011 Aug 11.

PMID:
21836037
27.

Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17, SLC22A17) and its prognostic significance in endometrial carcinoma.

Miyamoto T, Asaka R, Suzuki A, Takatsu A, Kashima H, Shiozawa T.

Exp Mol Pathol. 2011 Oct;91(2):563-8. doi: 10.1016/j.yexmp.2011.06.002. Epub 2011 Jul 8.

PMID:
21763306
28.

Accelerated in vivo epidermal telomere loss in Werner syndrome.

Ishikawa N, Nakamura K, Izumiyama-Shimomura N, Aida J, Ishii A, Goto M, Ishikawa Y, Asaka R, Matsuura M, Hatamochi A, Kuroiwa M, Takubo K.

Aging (Albany NY). 2011 Apr;3(4):417-29.

29.

Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification.

Takeuchi K, Soda M, Togashi Y, Sugawara E, Hatano S, Asaka R, Okumura S, Nakagawa K, Mano H, Ishikawa Y.

Clin Cancer Res. 2011 May 15;17(10):3341-8. doi: 10.1158/1078-0432.CCR-11-0063. Epub 2011 Mar 23.

30.

Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma.

Takeuchi K, Soda M, Togashi Y, Ota Y, Sekiguchi Y, Hatano S, Asaka R, Noguchi M, Mano H.

Haematologica. 2011 Mar;96(3):464-7. doi: 10.3324/haematol.2010.033514. Epub 2010 Dec 6.

31.

Pathophysiological classification of functional dyspepsia using a novel drinking-ultrasonography test.

Kato M, Nishida U, Nishida M, Hata T, Asaka R, Haneda M, Yamamoto K, Imai A, Yoshida T, Ono S, Shimizu Y, Asaka M.

Digestion. 2010;82(3):162-6. doi: 10.1159/000308363. Epub 2010 Jun 25.

32.

Correlating phosphatidylinositol 3-kinase inhibitor efficacy with signaling pathway status: in silico and biological evaluations.

Dan S, Okamura M, Seki M, Yamazaki K, Sugita H, Okui M, Mukai Y, Nishimura H, Asaka R, Nomura K, Ishikawa Y, Yamori T.

Cancer Res. 2010 Jun 15;70(12):4982-94. doi: 10.1158/0008-5472.CAN-09-4172. Epub 2010 Jun 8.

33.

Role of insulin-like growth factor binding protein 2 in lung adenocarcinoma: IGF-independent antiapoptotic effect via caspase-3.

Migita T, Narita T, Asaka R, Miyagi E, Nagano H, Nomura K, Matsuura M, Satoh Y, Okumura S, Nakagawa K, Seimiya H, Ishikawa Y.

Am J Pathol. 2010 Apr;176(4):1756-66. doi: 10.2353/ajpath.2010.090500. Epub 2010 Feb 11.

Supplemental Content

Support Center